Moisturizers for the treatment of inflammatory skin conditions

Journal of Drugs in Dermatology

Volumn 7, Issue 11, 2008, Pages 1038-1043

  Lynde, Charles ^a  

^a Lynde Centre for Dermatology Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT;

ACNE VULGARIS; ATOPIC DERMATITIS; DERMATITIS; HUMAN; LUNG GAS EXCHANGE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; ROSACEA; SKIN;

ACNE VULGARIS; BLOOD-AIR BARRIER; DERMATITIS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HUMANS; ROSACEA; SKIN;

EID: 58749107700     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17(Suppl 1):43-48.
2. Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med J. 2006;47:293-306. (Pubitemid 43984155)
3. Tharp MD. The essentials of fundamental skin care: Scientific rationale and clinical applications. Anatomic and physiologic aspects of the skin barrier. Medscape. Available at: http://www.medscape.com/viewarticle/473453-1. Accessed April 27 2005.
4. Madison KC. Barrier function of the skin: "la raison d'etre" of the epidermis. J invest Dermatol. 2003;121:231-241.
5. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med. 1999;31:5-19. (Pubitemid 29164098)
6. Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4:771-788. (Pubitemid 37452637)
7. Kraft JN, Lynde CW. Moisturizers: what they are and a practical approach to product selection. Skin Therapy Lett. 2005;10:1-8.
8. Sandilands A, O'Regan GM, Liao H, et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol. 2006;126:1770-1775. (Pubitemid 44086511)
9. Lynde CW. Moisturizers: what they are and how they work. Skin Therapy Lett. 2001;6:3-5.
10. Loden M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005;19:672-688. (Pubitemid 41743319)
11. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatol Ther. 2004;17(Suppl 1):49-56.
12. Loden M. Do moisturizers work? J Cosmet Dermatol. 2003;2:141-149.
13. Short RW, Chan JL, Choi JM, Egbert BM, Rehmus WE, Kimball AB. Effects of moisturization on epidermal homeostasis and differentiation. Clin Exp Dermatol. 2007;32:88-90. (Pubitemid 46006376)
14. Ganemo A, Virtanen M, Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double-blind study of four different cream formulations. Br J Dermatol. 1999;141:1027-1032. (Pubitemid 30046190)
15. Loden M, Wessman C. The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int J Cosmet Sci. 2001;23:115-119. (Pubitemid 32374835)
16. Buraczewska I, Brostrom U, Loden M. Artificial reduction in transepidermal water loss improves skin barrier function. Br J Dermatol. 2007;157:82-86. (Pubitemid 46934275)
17. Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135-141. (Pubitemid 41290900)
18. Laquieze S, Czernielewski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatolog Treat. 2007;18:158-162. (Pubitemid 46854831)
19. Ghali FE. Improved clinical outcomes with moisturization in dermatologic disease. Cutis. 2005;76(6 Suppl):13-18. (Pubitemid 43094509)
20. Loden M, Andersson AC, Anderson C, et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol. 2002;82:45-47 (Pubitemid 34450544)
21. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47:198-208.
22. Soma Y Kashima M, Imaizumi A, et al. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol. 2005;44:197-202. (Pubitemid 40425662)
23. Andersson A-C, Lindberg M, Loden M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients: I. expert, patient and instrumental evaluation. J Dermatolog Treat. 1999;10:165-169. (Pubitemid 29438075)
24. Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol. 1999;140:264-267 (Pubitemid 29111354)
25. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-S37 (Pubitemid 36791495)
26. Laquieze S, Czernielewski J, Rueda MJ. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. J Drugs Dermatol. 2006;5:985-990.
27. Del Rosso JQ. The role of the vehicle in combination acne therapy. Cutis. 2005;76(2 Suppl):15-18. (Pubitemid 41290889)
28. Fagundes DS, Fraser JM, Klauda HC. Differences in the irritation potential and cosmetic acceptability of two combination topical acne gels: combined results of two comparative studies. Today's Ther Trends. 2003;21:269-275. (Pubitemid 36988324)
29. Zhen Y Stoudemayer M, Vamvakias G, Kligman AM. Pilot investigation of the hydrating effects of topical acne medications. J Drugs Dermatol. 2007;6:810-816.
30. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7:231-236. (Pubitemid 44231918)
31. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol. 2005;152:1015-1021. (Pubitemid 40704945)